Vásquez-Márquez I, Castellanos-Olivares A

Idioma: Español
Referencias bibliográficas: 22
Paginas: 178-188
Archivo PDF: 221.51 Kb.

FRAGMENTO

Introducción

Al revisar la literatura sobre farmacología perioperatoria en el paciente geriátrico, encontramos una cantidad enorme de escritos que aparecen relacionados con el tema, por esa razón es necesario revisar continuamente puntos clave, auxiliares para dirigir un buen entendimiento del manejo farmacológico de quien prescribe a los pacientes ancianos.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Bettelli G. Preoperative evaluation in geriatric surgery: comorbidity functional status and Pharmacological history. Minerva Anestesiol. 2011;77:637-646.

2. Griffiths R, Beech F, Brown AI, Dhesi J, Foo I, Goodall J. AAGBI safety guideline peri-operative care of the elderly. Anesthesia. 2014;69:81-98.

3. Okuyama A, Martowirono K, Bijnen B. Assessing the patient safety competencies of healthcare professionals: a systematic review. Br J Med. 2011;20:991-1000.

4. Boeker EB, Boer M, Kiewiet JJ, Lie-A-Huen L, Dijkgraaf MG, Boermeester MA. Occurrence and preventability of adverse drug events in surgical patients: a systematic review of literature. Health Serv Res. 2013;28:13:364.

5. Cruz-Pardos P, Fernández-Riveira C, Garutti I. Betabloqueantes: utilidad perioperatoria en cirugía no cardíaca. Rev Esp Anestesiol Reanim. 2005;52:617-626.

6. Singh A, Antognini JF. Perioperative pharmacology in elderly patients. Curr Opin Anaesthesiol. 2010;23:449-454.

7. Wooten JM. Pharmacotherapy considerations in elderly adults. South Med J. 2012;105:437-445.

8. Rivera R, Antognini JF. Perioperative drug therapy in elderly. Anaesthesiol. 2009;110:1176-1181.

9. McLachlan AJ, Pont LG. Drug metabolism in older people. A key consideration in achieving optimal outcomes with medicines. J Gerontol A Biol Sci Med Sci. 2012;67:175-180.

10. Dimitrow MS, Airaksinen MS, Kivelä LS, Lyles AS, Leikola SN. Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review. J of Amer Geriatrics Soc. 2011;59:1521-1530.

11. Górriz T JL, Beltrán CS. Valoración de afección renal, disfunción renal aguda e hiperpotasemia por fármacos usados en cardiología y nefrotoxicidad por contrastes. Rev Esp Cardiol. 2011;64:1182-1192.

12. Brubaker HP, Kitzman WD. Chronotropic incompetence: causes, consequences, and management. Circulation. 2011;123:1010-1020.

13. Marsden CD, Jenner P. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med. 2009;39:1055-1072.

14. Ralph IE, Jeffrey KA. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255-1259.

15. Arnaiz JA, Carné X, Riba N, Codina C, Ribas J, Trilla A. The use of evidence in pharmacovigilance. Eur J Clin Pharmacol. 2001;57:89-91.

16. Wester K, Jönsson KA, Spigset O, Druid H, Hägg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol. 2008;65:573-579.

17. Hartshorn EA. Drug interaction. Ann Pharm. 2006;40:112-113.

18. Egger SS, Drewe J, Schlienger RG. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol. 2003;58:773-777.

19. Köhler GL, Böger RH, Busse R. Drug-drug interactions in medical patients: effects of in hospital treatment and relation to multiple drug use. Int J Clin Pharmacol. 2000;38:504-513.

20. Mahony OD, Sullivan DO, Byrne S, Connor MN, Ryan C, Gallagher P. Stopp/Start criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213-218.

21. Fick D, Semla T, Beizer J, Brandt N, Dombrowski R, DuBeau CE. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616-631.

22. Spell NO. Stopping and restarting medications in the preoperative period. Med Clin N Am. 2001;85:1117-1128.